Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-13 Sale | 2025-11-13 9:20 pm | Metsera Inc. | MTSR | BERNS PAUL L Director | 16,798,952 | $0 | $0 | 4,031 (Indirect Direct) | View |
| 2025-02-18 Sale | 2025-02-20 5:14 pm | Neumora Therapeutics Inc. | NMRA | BERNS PAUL L See Remarks | 13,871 | $1.6919 | $23,468 | 7,804,295 (Indirect Direct) | View |
| 2025-02-03 Purchase | 2025-02-03 7:04 pm | Metsera Inc. | MTSR | BERNS PAUL L Director | 789,998 | $18 | $14,219,964 | 9,271,239 (Indirect Direct) | View |
| 2023-11-09 Sale | 2023-11-09 4:18 pm | EQRx Inc. | EQRX | BERNS PAUL L Director | 627,000 | $0 | $0 | 0 (Direct) | View |
| 2021-08-05 Sale | 2021-08-09 6:37 pm | Jazz Pharmaceuticals plc | JAZZ | BERNS PAUL L Director | 1,450 | $154 | $223,300 | 8,290 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-11-13 Option Award | 2025-11-13 9:20 pm | N/A N/A | Metsera Inc. | MTSR | BERNS PAUL L Director | 4,031 | $0 | 4,031 (Direct) | View |
Ownership | 2025-07-29 9:23 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | ARCH Venture Fund XIII L.P. ARCH Venture Partners XIII L.P. ARCH Venture Partners XIII LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN BERNS PAUL L 10% Owner | 0 | $0 | 938,438 (Indirect) | View |
| 2025-05-28 Option Award | 2025-05-30 6:30 pm | N/A 2032-01-27 | Neumora Therapeutics Inc. | NMRA | BERNS PAUL L See Remarks | 3,795,413 | $0 | 3,795,413 (Direct) | View |
| 2025-05-20 Option Award | 2025-05-22 7:33 pm | N/A 2035-05-19 | Metsera Inc. | MTSR | BERNS PAUL L Director | 24,188 | $0 | 24,188 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:30 pm | N/A 2035-02-13 | Neumora Therapeutics Inc. | NMRA | BERNS PAUL L See Remarks | 3,795,413 | $0 | 3,795,413 (Direct) | View |
| 2025-02-03 Conversion | 2025-02-03 7:04 pm | N/A N/A | Metsera Inc. | MTSR | BERNS PAUL L Director | 25,202,253 | $0 | 9,271,239 (Indirect) | View |
Ownership | 2025-01-30 9:37 pm | N/A N/A | Metsera Inc. | MTSR | BERNS PAUL L Director 10% Owner | 0 | $0 | 8,704,671 (Direct) | View |
| 2024-12-27 Gift | 2024-12-27 5:01 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | BERNS PAUL L Director | 133,097 | $0 | 7,818,166 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-21 4:30 pm | N/A 2034-06-20 | Unity Biotechnology Inc. | UBX | BERNS PAUL L Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:17 pm | N/A 2034-02-13 | Neumora Therapeutics Inc. | NMRA | BERNS PAUL L Director | 513,750 | $0 | 8,160,666 (Direct) | View |
Ownership | 2023-09-14 6:59 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | BERNS PAUL L Director | 0 | $0 | 9,188,536 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 5:12 pm | N/A 2033-06-22 | Unity Biotechnology Inc. | UBX | BERNS PAUL L Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 9:57 pm | N/A 2024-12-17 | EQRx Inc. | EQRX | BERNS PAUL L Director | 453 | $0 | 86,344 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-04 8:07 pm | N/A 2032-09-30 | EQRx Inc. | EQRX | BERNS PAUL L Director | 101,010 | $0 | 101,010 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-27 5:43 pm | N/A 2032-06-23 | Unity Biotechnology Inc. | UBX | BERNS PAUL L Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 06:30 am | N/A 2024-12-17 | EQRx Inc. | EQRX | BERNS PAUL L Director | 712,891 | $0 | 712,891 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 5:15 pm | N/A 2031-06-23 | Unity Biotechnology Inc. | UBX | BERNS PAUL L Director | 25,000 | $0 | 25,000 (Direct) | View |